Abstract
For the last two decades, iron deficiency has been categorized as either absolute or functional. Absolute iron deficiency implies that there is a deficiency in total body iron stores, such that there are inadequate levels of iron to supply the bone marrow. The two types of iron deficiency are often compared to a bank account. Absolute iron deficiency implies that there is simply not enough money in the bank to be able to make a withdrawal. Functional iron deficiency is a condition in which there are normal or even increased levels of total body iron stores, but there is a failure to mobilize this iron for use by the bone marrow for erythropoiesis. To continue the bank account analogy, functional iron deficiency is illustrated by a condition in which there is an ample amount of money in a savings account, but it cannot be withdrawn on demand.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Macdougall IC. Monitoring of iron status and iron supplementation in patients treated with erythropoietin. Curr Opin Nephrol Hypertens. 1994;3:620-625.
Babitt JL, Lin HY. Molecular mechanisms of hepcidin regulation: implications for the anemia of CKD. Am J Kidney Dis. 2010;55:726-741.
Tessitore N, Solero GP, Lippi G, et al. The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance erythropoietin. Nephrol Dial Transplant. 2001;16:1416-1423.
Beguin Y. Soluble transferrin receptor for the evaluation of erythropoiesis and iron status. Clin Chim Acta. 2003;329:9-22.
Tessitore N, Girelli D, Campostrini N, et al. Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents. Nephrol Dial Transplant. 2010;25:3996-4002.
Macdougall IC. Strategies for iron supplementation: oral versus intravenous. Kidney Int Suppl. 1999;69:S61-S66.
Charytan C, Qunibi W, Bailie GR; Venofer Clinical Studies Group. Comparison of intravenous iron sucrose to oral iron in the treatment of anemic patients with chronic kidney disease not on dialysis. Nephron Clin Pract. 2005;100:c55-c62.
Bailie GR, Horl WH, Verhoef JJ. Differences in spontaneously reported hypersensitivity and serious adverse events for intravenous iron preparations: comparison of Europe and North America. Arzneimittelforschung. 2011;61:267-275.
Chandler G, Harchowal J, Macdougall IC. Intravenous iron sucrose: establishing a safe dose. Am J Kidney Dis. 2001;38:988-991.
Ferinject [package insert]. Neuilly-sur-Seine, France: Vifor Pharma; 2011.
Monofer [package insert]. Holbaek, Denmark: Pharmacosmos; 2009.
Feraheme [package insert]. Lexington, MA: AMAG Pharmaceuticals; 2011.
Toblli JE, Cao G, Oliveri L, Angerosa M. Assessment of the extent of oxidative stress induced by intravenous ferumoxytol, ferric carboxymaltose, iron sucrose and iron dextran in a nonclinical model. Arzneimittelforschung. 2011;61:399-410.
Venofer [package insert]. Shirley, NY: American Regent; 2011.
Toblli JE, Cao G, Oliveri L, Angerosa M. Comparison of oxidative stress and inflammation induced by different intravenous iron sucrose similar preparations in a rat model. Inflamm Allergy Drug Targets. 2012;11:66-78.
Locatelli F, Aljama P, Barany P, et al. Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant. 2004;19(suppl 2):ii1-47.
Bailie GR, Clark JA, Lane CE, et al. Hypersensitivity reactions and deaths associated with intravenous iron preparations. Nephrol Dial Transplant. 2005;20:1443-1449.
National Kidney Foundation. KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int Suppl. 2012;2:v-335.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Healthcare
About this chapter
Cite this chapter
Macdougall, I.C. (2013). Iron Management. In: Pocket Reference to Renal Anemia. Springer Healthcare, Tarporley. https://doi.org/10.1007/978-1-907673-48-1_5
Download citation
DOI: https://doi.org/10.1007/978-1-907673-48-1_5
Published:
Publisher Name: Springer Healthcare, Tarporley
Print ISBN: 978-1-908517-74-6
Online ISBN: 978-1-907673-48-1
eBook Packages: MedicineMedicine (R0)